glutathione depletion acrolein The overall mechanism regarding acrolein-induced HC pathogenesis. (I) Acrolein toxicity involves oxidative stress

Balabanian, K

Cagrilintide is in development as a monotherapy for the treatment of overweight and obesity and as a fixed-dose combination with the glucagon-like peptide-1 receptor agonist, semaglutide (CagriSema) for the treatment of overweight, obesity and type 2 diabetes

Im only going to dread one day at a time. by Charles M

Patients already on a stable GLP-1 protocol who want metabolic support during their fat-loss phase tend to do well adding MOTS-C two or three times per week

Acta Physiol Scand Suppl 24:751

Expression of an anaplerotic enzyme, pyruvate carboxylase, improves recombinant protein production in Escherichia coli